• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四周食用大豆科力豆腐对心血管代谢健康标志物的影响:胆固醇水平轻度升高的成年人中进行的双盲随机对照交叉试验。

Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels.

机构信息

Wageningen Food and Biobased Research, Wageningen University & Research, 6708 WG Wageningen, The Netherlands.

Department of Cardiology, Ziekenhuis Gelderse Vallei, 6710 HN Ede, The Netherlands.

出版信息

Nutrients. 2022 Dec 22;15(1):49. doi: 10.3390/nu15010049.

DOI:10.3390/nu15010049
PMID:36615709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9824620/
Abstract

Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross-over trial, 45 subjects aged 40-70 years with (mildly) elevated cholesterol levels, received a four week Kori-tofu intervention or whey protein control intervention with a four week wash-out period in between. Cardiometabolic biomarkers were measured before and after both interventions. A significant decrease in total, low-density lipids (LDL), and high-density lipids (HDL) cholesterol, Hemoglobin A1c (HbA1c), fructosamine and systolic blood pressure was observed within the Kori-tofu intervention. However, many of these findings were also observed in the control intervention. Only adiponectin changes were different between treatments but did not change significantly within interventions. Improvements in cardiometabolic markers within the Kori-tofu intervention point toward potential beneficial health effects. Due to the lack of significant effects as compared to control, there is, however, currently no substantiating evidence to claim that Kori-tofu has beneficial effects on cardiometabolic health.

摘要

科里豆腐是一种冷冻豆腐,大豆的摄入与改善心血管代谢健康标志物有关。我们旨在通过重复日常摄入来评估科里豆腐对改善人体心血管代谢健康结果的潜力。在一项双盲随机对照交叉试验中,45 名年龄在 40-70 岁、胆固醇水平(轻度)升高的受试者接受了为期四周的科里豆腐干预或乳清蛋白对照干预,中间有四周的洗脱期。在两次干预前后均测量了心血管代谢生物标志物。在科里豆腐干预期间,总胆固醇、低密度脂蛋白 (LDL)、高密度脂蛋白 (HDL) 胆固醇、糖化血红蛋白 (HbA1c)、果糖胺和收缩压均显著下降。然而,在对照干预中也观察到了许多这些发现。只有脂联素的变化在两种治疗方法之间有所不同,但在干预过程中并没有显著变化。科里豆腐干预期间心血管代谢标志物的改善表明其可能对健康有益。然而,由于与对照相比,效果不显著,目前没有确凿的证据表明科里豆腐对心血管代谢健康有有益的影响。

相似文献

1
Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels.四周食用大豆科力豆腐对心血管代谢健康标志物的影响:胆固醇水平轻度升高的成年人中进行的双盲随机对照交叉试验。
Nutrients. 2022 Dec 22;15(1):49. doi: 10.3390/nu15010049.
2
Cholesterol-lowering effect of kori-tofu protein and its high-molecular-weight fraction content.kori豆腐蛋白及其高分子量组分含量的降胆固醇作用。
Biosci Biotechnol Biochem. 2011;75(3):575-7. doi: 10.1271/bbb.100634. Epub 2011 Mar 7.
3
A Non-Probiotic Fermented Soy Product Reduces Total and LDL Cholesterol: A Randomized Controlled Crossover Trial.一种非益生菌发酵大豆制品可降低总胆固醇和 LDL 胆固醇:一项随机对照交叉试验。
Nutrients. 2021 Feb 6;13(2):535. doi: 10.3390/nu13020535.
4
Probiotic Soy Product Supplemented with Isoflavones Improves the Lipid Profile of Moderately Hypercholesterolemic Men: A Randomized Controlled Trial.补充异黄酮的益生菌大豆产品改善中度高胆固醇血症男性的血脂状况:一项随机对照试验。
Nutrients. 2016 Jan 19;8(1):52. doi: 10.3390/nu8010052.
5
Longer-term soy nut consumption improves vascular function and cardiometabolic risk markers in older adults: Results of a randomized, controlled cross-over trial.长期食用大豆坚果可改善老年人的血管功能和心血管代谢风险指标:一项随机对照交叉试验的结果
Clin Nutr. 2022 May;41(5):1052-1058. doi: 10.1016/j.clnu.2022.03.014. Epub 2022 Mar 14.
6
Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic adults: a randomized trial.两种豆浆和牛奶对高胆固醇血症成年人血脂的影响:一项随机试验。
J Am Coll Nutr. 2007 Dec;26(6):669-77. doi: 10.1080/07315724.2007.10719646.
7
Effect of soy and milk protein supplementation on serum lipid levels: a randomized controlled trial.大豆和牛奶蛋白补充对血清脂质水平的影响:一项随机对照试验。
Eur J Clin Nutr. 2012 Apr;66(4):419-25. doi: 10.1038/ejcn.2011.168. Epub 2011 Sep 28.
8
An Intervention with Mineral Water Decreases Cardiometabolic Risk Biomarkers. A Crossover, Randomised, Controlled Trial with Two Mineral Waters in Moderately Hypercholesterolaemic Adults.饮用矿泉水干预可降低心脏代谢风险生物标志物水平。一项针对中度高胆固醇血症成年人的两种矿泉水交叉、随机、对照试验。
Nutrients. 2016 Jun 28;8(7):400. doi: 10.3390/nu8070400.
9
No Effect of Isolated Anthocyanins from Bilberry Fruit and Black Rice on LDL Cholesterol or other Biomarkers of Cardiovascular Disease in Adults with Elevated Cholesterol: A Randomized, Placebo-Controlled, Cross-Over Trial.黑果腺肋花楸果和黑米中分离的花色苷对胆固醇升高成年人 LDL 胆固醇或心血管疾病其他生物标志物无影响:一项随机、安慰剂对照、交叉试验。
Mol Nutr Food Res. 2022 Nov;66(21):e2101157. doi: 10.1002/mnfr.202101157. Epub 2022 Apr 26.
10
Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia.用膳食大豆蛋白和油替代高胆固醇血症患者膳食中的乳蛋白和脂肪的效果。
Clin Invest Med. 1997 Jun;20(3):162-70.

引用本文的文献

1
Exploring the Impact of Personalized Nutritional Approaches on Metabolism and Immunity: A Systematic Review of Various Nutrients and Dietary Patterns.探索个性化营养方法对代谢和免疫的影响:对各种营养素和饮食模式的系统评价
Cureus. 2024 Apr 18;16(4):e58553. doi: 10.7759/cureus.58553. eCollection 2024 Apr.

本文引用的文献

1
Effects of Soy Isoflavones on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.大豆异黄酮对 2 型糖尿病患者血糖控制和血脂谱的影响:系统评价和随机对照试验的荟萃分析。
Nutrients. 2021 May 31;13(6):1886. doi: 10.3390/nu13061886.
2
Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease.胆汁酸在调节食物摄入中的作用,及其在代谢性疾病中的失调。
Nutrients. 2021 Mar 28;13(4):1104. doi: 10.3390/nu13041104.
3
Effects of whey protein on glycemic control and serum lipoproteins in patients with metabolic syndrome and related conditions: a systematic review and meta-analysis of randomized controlled clinical trials.
乳清蛋白对代谢综合征及相关疾病患者血糖控制和血清脂蛋白的影响:一项随机对照临床试验的系统评价和荟萃分析。
Lipids Health Dis. 2020 Sep 21;19(1):209. doi: 10.1186/s12944-020-01384-7.
4
High Blood Pressure and Cardiovascular Disease.高血压与心血管疾病。
Hypertension. 2020 Feb;75(2):285-292. doi: 10.1161/HYPERTENSIONAHA.119.14240. Epub 2019 Dec 23.
5
Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: A systematic review and meta-analysis.代谢综合征患者的生活方式干预的效果:系统评价和荟萃分析。
Metabolism. 2019 Dec;101:153988. doi: 10.1016/j.metabol.2019.153988. Epub 2019 Oct 28.
6
A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.一项由 FDA 确定的 46 项研究的荟萃分析表明,大豆蛋白可降低成年人的循环 LDL 和总胆固醇浓度。
J Nutr. 2019 Jun 1;149(6):968-981. doi: 10.1093/jn/nxz020.
7
Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis.法尼醇X受体(FXR)与G蛋白偶联胆汁酸受体5(TGR5)之间的相互作用调控胰高血糖素样肽-1的分泌以维持血糖稳态。
Lab Anim Res. 2018 Dec;34(4):140-146. doi: 10.5625/lar.2018.34.4.140. Epub 2018 Dec 31.
8
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
9
A Systematic Review of the Effects of Plant Compared with Animal Protein Sources on Features of Metabolic Syndrome.植物蛋白源与动物蛋白源对代谢综合征特征影响的系统评价
J Nutr. 2017 Mar;147(3):281-292. doi: 10.3945/jn.116.239574. Epub 2017 Jan 25.
10
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.糖尿病前期与心血管疾病风险及全因死亡率之间的关联:系统评价与荟萃分析
BMJ. 2016 Nov 23;355:i5953. doi: 10.1136/bmj.i5953.